Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,579 | -66,303 | -47,617 | -19,704 | -54,780 |
| Depreciation Amortization | 3,819 | 2,194 | 1,038 | 386 | 728 |
| Accounts payable and accrued liabilities | 3,581 | 84 | 395 | 1,331 | 2,682 |
| Other Working Capital | 114,824 | 115,968 | 114,050 | 116,775 | 3,140 |
| Other Operating Activity | 13,276 | 12,783 | 8,227 | 2,627 | 7,386 |
| Operating Cash Flow | $43,921 | $64,726 | $76,093 | $101,415 | $-40,844 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21,492 | -15,805 | -9,946 | -3,400 | -4,362 |
| Purchase Of Investment | -290,594 | -245,728 | -206,534 | -45,301 | -267,761 |
| Sale Of Investment | 246,494 | 176,230 | 125,335 | 66,425 | 136,390 |
| Other Investing Activity | 0 | 117 | -1 | -1 | -1,400 |
| Investing Cash Flow | $-65,592 | $-85,186 | $-91,146 | $17,723 | $-137,133 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2,600 |
| Common Stock Issued | 2,138 | 2,138 | 944 | 157 | 140,349 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -24 |
| Financing Cash Flow | $2,138 | $2,138 | $944 | $157 | $137,725 |
| Beginning Cash Position | 75,472 | 73,933 | 73,933 | 73,933 | 114,185 |
| End Cash Position | 55,939 | 55,611 | 59,824 | 193,228 | 73,933 |
| Net Cash Flow | $-19,533 | $-18,322 | $-14,109 | $119,295 | $-40,252 |
| Free Cash Flow | |||||
| Operating Cash Flow | 43,921 | 64,726 | 76,093 | 101,415 | -40,844 |
| Capital Expenditure | -21,492 | -15,805 | -9,946 | -3,400 | -4,362 |
| Free Cash Flow | 22,429 | 48,921 | 66,147 | 98,015 | -45,206 |